Loading clinical trials...
Loading clinical trials...
This is a multi-center, prospective, randomized, controlled study. The patients with STEMI who were to undergo PPCI were divided into PCSK9 inhibitor group (n=80) and conventional treatment group (n=8...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Tong Ren Hospital
Collaborators
NCT06939738 · Acute Myocardial Infarction (AMI)
NCT04528511 · Atrial Fibrillation New Onset, Acute Myocardial Infarction
NCT06744322 · Acute Myocardial Infarction (AMI)
NCT07293923 · Cardiogenic Shock, Heart Failure, and more
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
nineth people's hospital, School of Medicine, shanghai jiaotong university
Shanghai, Shanghai Municipality
Shanghai chest hospital
Shanghai, Shanghai Municipality
Shanghai tongren hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions